期刊
TRENDS IN PHARMACOLOGICAL SCIENCES
卷 28, 期 2, 页码 51-60出版社
ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tips.2006.12.002
关键词
-
There is strong evidence that protein kinase C (PKC) isozyme signaling pathways are causally involved in associative memory storage. Other observations have indicated that PKC signaling pathways regulate important molecular events in the neurodegenerative pathophysiology of Alzheimer's disease (AD), which is a progressive dementia that is characterized by loss of recent memory. This parallel involvement of PKC signaling in both memory and neurodegeneration indicates a common basis for the origins of both the symptoms and the pathology of AD. Here, we discuss this conceptual framework as a basis for an autopsy-validated peripheral biomarker - and for AD drug design targeting drugs (bryostatin and bryologs) that activate PKC isozymes that has already demonstrated significant promise for treating both AD neurodegeneration and its symptomatic memory loss.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据